| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/7854_2015_5006 |
| P698 | PubMed publication ID | 27240677 |
| P50 | author | Wolfgang H Sommer | Q37828763 |
| P2093 | author name string | Rainer Spanagel | |
| Markus Heilig | |||
| P2860 | cites work | Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior | Q22241964 |
| Subjective and neural responses to intravenous alcohol in young adults with light and heavy drinking patterns | Q22251050 | ||
| Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction | Q24320057 | ||
| Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 | ||
| Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? | Q24600288 | ||
| Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol | Q24647841 | ||
| Requirement of central ghrelin signaling for alcohol reward | Q24656030 | ||
| Glutamatergic targets for new alcohol medications | Q26824012 | ||
| Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism | Q27014879 | ||
| The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. | Q27863346 | ||
| The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption | Q28299078 | ||
| Acamprosate produces its anti-relapse effects via calcium | Q28299533 | ||
| Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors | Q28592400 | ||
| Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats | Q29619737 | ||
| Linking nucleus accumbens dopamine and blood oxygenation. | Q31097702 | ||
| Enhancement of extinction learning attenuates ethanol-seeking behavior and alters plasticity in the prefrontal cortex. | Q33671679 | ||
| Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications | Q33884216 | ||
| Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward | Q33996593 | ||
| Drug harms in the UK: a multicriteria decision analysis | Q34024516 | ||
| A genetic determinant of the striatal dopamine response to alcohol in men | Q34077390 | ||
| Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder | Q34114364 | ||
| Sex Differences in Striatal Dopamine Release in Young Adults After Oral Alcohol Challenge: A Positron Emission Tomography Imaging Study With [11C]Raclopride | Q34172920 | ||
| Naltrexone in the treatment of alcohol dependence | Q34241680 | ||
| The relationship between impulsive choice and impulsive action: a cross-species translational study. | Q34264963 | ||
| Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions | Q34338064 | ||
| Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis | Q34419898 | ||
| Ethanol-induced alterations of amino acids measured by in vivo microdialysis in rats: a meta-analysis | Q34503542 | ||
| Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions | Q34770260 | ||
| Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients | Q34941455 | ||
| Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence | Q35128787 | ||
| Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty | Q35195803 | ||
| The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview | Q35203806 | ||
| Dopamine in drug abuse and addiction: results from imaging studies and treatment implications | Q35751195 | ||
| TE-averaged two-dimensional proton spectroscopic imaging of glutamate at 3 T. | Q46683485 | ||
| Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats | Q46711542 | ||
| Drugs for relapse prevention of alcoholism: ten years of progress | Q46762261 | ||
| Modafinil modulates resting-state functional network connectivity and cognitive control in alcohol-dependent patients. | Q48168120 | ||
| First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study | Q48218651 | ||
| Awake rat pharmacological magnetic resonance imaging as a translational pharmacodynamic biomarker: metabotropic glutamate 2/3 agonist modulation of ketamine-induced blood oxygenation level dependence signals | Q48303321 | ||
| Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels | Q48309259 | ||
| Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats | Q48386138 | ||
| Translating intermediate phenotypes to psychopathology: the NIMH Research Domain Criteria | Q48459490 | ||
| Revolution stalled | Q48598091 | ||
| Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies | Q48623993 | ||
| Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. | Q48921857 | ||
| Effect of modafinil on impulsivity and relapse in alcohol dependent patients: a randomized, placebo-controlled trial. | Q50736379 | ||
| Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. | Q51594388 | ||
| Is pharma running out of brainy ideas? | Q51847289 | ||
| Are metabotropic glutamate receptors promising targets for the treatment of alcoholism? | Q51853023 | ||
| Endophenotypes: bridging genomic complexity and disorder heterogeneity. | Q51860875 | ||
| Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. | Q51889085 | ||
| Alteration of ethanol self-administration by naltrexone. | Q52298963 | ||
| Alcohol dependence: provisional description of a clinical syndrome | Q57482712 | ||
| Brain-specific inactivation of the Crhr1 gene inhibits post-dependent and stress-induced alcohol intake, but does not affect relapse-like drinking | Q35760218 | ||
| Pharmacogenetic approaches to the treatment of alcohol addiction | Q36126591 | ||
| Imaging the dopamine system with in vivo [11C]raclopride displacement studies: understanding the true mechanism | Q36136737 | ||
| Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? | Q36327334 | ||
| Medications development to treat alcohol dependence: a vision for the next decade | Q36357552 | ||
| Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms | Q36424583 | ||
| Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study | Q36641425 | ||
| Resting-state synchrony in short-term versus long-term abstinent alcoholics | Q36798305 | ||
| A key role for corticotropin-releasing factor in alcohol dependence | Q36880698 | ||
| Rescue of infralimbic mGluR2 deficit restores control over drug-seeking behavior in alcohol dependence | Q37011912 | ||
| Addiction and the brain antireward system | Q37043564 | ||
| Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol | Q37107238 | ||
| A multistep general theory of transition to addiction. | Q37157966 | ||
| Loss of metabotropic glutamate receptor 2 escalates alcohol consumption | Q37240383 | ||
| Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis | Q37370760 | ||
| Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. | Q37533517 | ||
| Chronic alcohol disrupts dopamine receptor activity and the cognitive function of the medial prefrontal cortex | Q37617401 | ||
| Association of µ-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis | Q38003649 | ||
| Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. | Q38133045 | ||
| Postdependent state in rats as a model for medication development in alcoholism | Q38268791 | ||
| Reward and relief craving tendencies in patients with alcohol use disorders: results from the PREDICT study | Q39238456 | ||
| Global ethanol-induced enhancements of monoaminergic neurotransmission: a meta-analysis study | Q39394867 | ||
| Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans | Q42551362 | ||
| Suppression of alcohol self-administration and reinstatement of alcohol seeking by melanin-concentrating hormone receptor 1 (MCH1-R) antagonism in Wistar rats | Q42971102 | ||
| Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques | Q44334193 | ||
| A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients | Q44341917 | ||
| A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. | Q44350045 | ||
| Alcohol promotes dopamine release in the human nucleus accumbens | Q44492239 | ||
| Understanding US addiction physicians' low rate of naltrexone prescription | Q44574555 | ||
| Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene | Q44745407 | ||
| Measurement of brain glutamate using TE-averaged PRESS at 3T. | Q44789170 | ||
| Excess mortality of alcohol-dependent individuals after 14 years and mortality predictors based on treatment participation and severity of alcohol dependence | Q44918017 | ||
| Into the valley of death: research to innovation | Q46428957 | ||
| Long-term stability of alcohol and other substance dependence diagnoses and habitual smoking: an evaluation after 5 years | Q46582837 | ||
| Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum | Q46600038 | ||
| P921 | main subject | alcoholism | Q15326 |
| biomarker | Q864574 | ||
| P304 | page(s) | 151-171 | |
| P577 | publication date | 2016-05-31 | |
| P1433 | published in | Current topics in behavioral neurosciences | Q26842118 |
| P1476 | title | The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research | |
| P478 | volume | 28 |
| Q90597805 | Developing neuroscience-based treatments for alcohol addiction: A matter of choice? |
| Q102379344 | Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder |
| Q30399543 | Don't stress about CRF: assessing the translational failures of CRF1antagonists |
| Q100465301 | Improving translation of animal models of addiction and relapse by reverse translation |
| Q52630083 | Increased Alcohol Seeking in Mice Lacking Gpr88 Involves Dysfunctional Mesocorticolimbic Networks. |
| Q51438275 | Nociceptin Receptor as a Target to Treat Alcohol Use Disorder: Challenges in Advancing Medications Development. |
| Q38608450 | Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives |
| Q38961620 | Reprogramming of mPFC transcriptome and function in alcohol dependence |
| Q38907719 | The GABAB Positive Allosteric Modulator ADX71441 Attenuates Alcohol Self-Administration and Relapse to Alcohol Seeking in Rats. |
Search more.